We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$29.6B
AUM Growth
+$4.22B
(+17%)
Cap. Flow
+$2.91B
Cap. Flow
% of AUM
9.83%
Top 10 Holdings %
Top 10 Hldgs %
7.91%
Holding
2,390
New
174
Increased
1,221
Reduced
844
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$184M |
| 2 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$158M |
| 3 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$136M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$123M |
| 5 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$120M |
| 2 |
Conagra Brands
CAG
|
+$72.2M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$61.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$55.9M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$50.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 12.87% |
| 3 | Consumer Discretionary | 10.2% |
| 4 | Consumer Staples | 9.25% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
N
151
DELISTED
Netsuite Inc
N
| $45.9M | 0.15% |
420,595
+16,675
| +4% | +$1.7M |
|
|
EVHC
152
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $45.9M | 0.15% |
441,475
+409,171
| +1,267% | +$42.1M |
|
153
Edison International
EIX
$30.9B
| $45.1M | 0.15% |
689,494
+366,274
| +113% | +$22.8M |
|
154
Applied Materials
AMAT
$431B
| $45M | 0.15% |
1,805,175
-99,422
| -5% | -$2.25M |
|
|
GXP
155
DELISTED
Great Plains Energy Incorporated
GXP
| $44.6M | 0.15% |
1,571,066
+793,825
| +102% | +$21M |
|
156
Church & Dwight Co
CHD
$23B
| $44.5M | 0.15% |
1,128,296
+1,109,030
| +5,756% | +$41M |
|
157
Marriott International
MAR
$97.7B
| $44.4M | 0.15% |
569,237
+42,393
| +8% | +$3.13M |
|
|
WR
158
DELISTED
Westar Energy Inc
WR
| $44M | 0.15% |
1,067,990
+458,541
| +75% | +$17.5M |
|
159
NVIDIA
NVDA
$5.03T
| $43.7M | 0.15% |
87,191,520
+18,807,640
| +28% | +$9.16M |
|
160
Jazz Pharmaceuticals
JAZZ
$15.9B
| $43.4M | 0.15% |
265,088
-14,827
| -5% | -$2.46M |
|
161
Labcorp
LH
$24.3B
| $43.3M | 0.15% |
466,894
+24,415
| +6% | +$2.16M |
|
|
ICPT
162
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $43.2M | 0.15% |
277,185
+265,900
| +2,356% | +$49.1M |
|
163
PG&E
PCG
$47.8B
| $43.2M | 0.15% |
811,414
+216,254
| +36% | +$10.7M |
|
|
SLXP
164
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $43.2M | 0.15% |
375,813
-89,516
| -19% | -$10.8M |
|
|
SNDK
165
DELISTED
SANDISK CORP
SNDK
| $43.1M | 0.15% |
439,904
+16,200
| +4% | +$1.55M |
|
166
Edgewell Personal Care
EPC
$1.26B
| $42.9M | 0.14% |
450,347
+127,614
| +40% | +$11.7M |
|
167
NetApp
NTAP
$32.5B
| $42.8M | 0.14% |
1,033,039
+18,588
| +2% | +$772K |
|
168
KLA
KLAC
$277B
| $42.6M | 0.14% |
6,060,840
+2,896,980
| +92% | +$21.4M |
|
169
Travelers Companies
TRV
$80.3B
| $42.6M | 0.14% |
402,151
+17,244
| +4% | +$1.74M |
|
|
CSC
170
DELISTED
Computer Sciences
CSC
| $42.6M | 0.14% |
1,601,595
+225,948
| +16% | +$5.82M |
|
171
Pediatrix Medical
MD
$2.15B
| $42.5M | 0.14% |
642,841
+49,576
| +8% | +$3.03M |
|
172
Best Buy
BBY
$17.9B
| $41.9M | 0.14% |
1,074,627
-68,552
| -6% | -$2.41M |
|
|
CTRX
173
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $41.8M | 0.14% |
807,400
+343,821
| +74% | +$16.2M |
|
174
Groupon
GRPN
$976M
| $41.6M | 0.14% |
251,671
+86,031
| +52% | +$12.2M |
|
175
Simon Property Group
SPG
$74.1B
| $40.6M | 0.14% |
222,737
+57,694
| +35% | +$10.2M |
|
Similar funds
DAM
First Trust Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, First Trust Advisors held 2,390 positions worth $29.6B, up 17% from $25.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
First Trust Advisors deployed $2.91B of net new capital in Q4 2014, opening 174 new positions and adding to 1,221 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $120M trimmed.
- First Trust Advisors's largest Q4 2014 buy was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
- First Trust Advisors added most to First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2014, an estimated $184M increase.
- First Trust Advisors's biggest Q4 2014 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $120M.
- First Trust Advisors fully exited Immunogen Inc in Q4 2014, selling an estimated $61.5M.
- First Trust Advisors's ten largest holdings make up 7.9% of its $29.6B portfolio in Q4 2014.
- First Trust Advisors opened 174 new positions and closed 147 in Q4 2014.
- First Trust Advisors's portfolio value rose 17% quarter-over-quarter to $29.6B.
Based on First Trust Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.